Floatz logo

Tazobactam

Stem Cell Transplantation

Wyeth is now a wholly owned subsidiary of PfizerSmall moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

6 Active assets in the Stem Cell Transplantation cohort.

Asset / SponsorPhaseRating
FILGRASTIM
National Cancer Institute (NCI)
Phase 2/3BBB
Thiotepa
medac GmbH
Phase 2BB
Evomela
Institute of Hematology & Blood Diseases Hospital, China
Phase 3BB
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
M.D. Anderson Cancer Center
Phase 2BB
Anti-Thymoglobulin, Rabbit
The First Affiliated Hospital of Soochow University
Phase 3BB

View all 12 →

Same molecule, other indications

Tazobactam is also rated in:

Pseudomonas infectionDormant
BB
Indicative ·
69 / 100
View asset →
bronchiectasisDormant
BB
Indicative ·
65 / 100
View asset →
Pseudomonas aeruginosa infectious diseaseDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →